Home
Conditions
AML (Acute Myeloid Leukemia)

Clinical trial condition

AML (Acute Myeloid Leukemia)

Explore clinical trials studying AML (Acute Myeloid Leukemia). Study availability and eligibility vary by location and protocol.

20 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

AML (Acute Myeloid Leukemia) trial results

Not Yet Recruiting

A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients

NCT07722767

Conditions: AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: City of Hope Duarte, California, United States

New York University Langone Health New York, United States

MD Anderson Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML

NCT07643636

Conditions: AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia

NCT07552649

Conditions: AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Azienda Ospedaliera di Perugia - Ospedale S. Maria della Misericordia Perugia, Italy

Presidio Ospedaliero Pescara - Azienda Sanitaria Locale di Pescara Pescara, Italy

View Trial Details

Not Yet Recruiting

FLT3-ITD Targeted Therapy in Fit AML Patients

NCT07425808

Conditions: AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia

NCT07370064

Conditions: AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The Affiliated Hospital oh Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

NCT07342244

Conditions: AML, AML (Acute Myeloid Leukemia), Hematologic Diseases, +6 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

NCT07338357

Conditions: AML (Acute Myeloid Leukemia), CAR-T, Hematologic Diseases, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

NCT07214064

Conditions: AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +12 more
Locations: University Hospital , Department of Internal Medicine II Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Not Yet Recruiting

Prognostic Impacts of Lipid Profile and BMI in Adult AML

NCT07143877

Conditions: AML (Acute Myeloid Leukemia), BMI, Hematologic Diseases, +8 more
Locations: Assiut university Hospitals Asyut, Asyut Governorate, Egypt

View Trial Details

Completed

Clinical Study of Selinexor-Based Chemotherapy With Minimal or No Cytotoxic Agents in Treatment-Naïve AML Patients Unsuitable for Intensive Therapy: Focusing on Rapid Reduction of Blast Cells

NCT07236931

Conditions: AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

AML (Acute Myeloid Leukemia)

AML (Acute Myeloid Leukemia) trial results

Related conditions